Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|88|6|321-331

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.6, 2015-0, pp. : 321-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 372-380

Karger

Access to resources Recommend Favorite

The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 361-368

Karger

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

By  

Oncology Research and Treatment, Vol. 36, Iss. 3, 2013-02 ,pp. : 95-100

Karger

Access to resources Recommend Favorite

Increased Transforming Growth Factor β1 Plasma Level in Patients with Renal Cell Carcinoma:A Tumor-Specific Marker?

By  

Urologia Internationalis, Vol. 60, Iss. 4, 1998-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite